We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+12.9%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$10B
AUM Growth
+$286M
Cap. Flow
-$560M
Cap. Flow %
-5.59%
Top 10 Hldgs %
8.88%
Holding
840
New
58
Increased
311
Reduced
332
Closed
78

Top Sells

Rank Stock Value
1
AL
Air Lease Corp
AL
+$64.5M
2
ENOV icon
Enovis
ENOV
+$51.5M
3
TGNA
TEGNA Inc
TGNA
+$36.1M
4
HAE icon
Haemonetics
HAE
+$35.3M
5
SPNS
Sapiens International
SPNS
+$31.5M

Sector Composition

Rank Sector Weight
1 Industrials 25.7%
2 Technology 19.16%
3 Financials 16.34%
4 Consumer Discretionary 13.92%
5 Healthcare 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTKB icon
426
Cytek Biosciences
CTKB
$557M
$6.12M 0.06%
1,763,262
+373,456
+27% +$1.4M
BLND icon
427
Blend Labs
BLND
$424M
$6.1M 0.06%
1,671,240
+709,989
+74% +$2.55M
CNTY icon
428
Century Casinos
CNTY
$33.2M
$6.08M 0.06%
2,329,491
-250,664
-10% -$625K
ESPR
429
DELISTED
Esperion Therapeutics
ESPR
$6.08M 0.06%
+2,293,488
New +$4.44M
SAMG icon
430
Silvercrest Asset Management
SAMG
$76.1M
$6.06M 0.06%
385,002
-183,291
-32% -$2.99M
INSG icon
431
Inseego
INSG
$111M
$6.06M 0.06%
+405,000
New +$4.08M
IPI icon
432
Intrepid Potash
IPI
$474M
$6M 0.06%
196,270
+3,250
+2% +$102K
TALK icon
433
Talkspace
TALK
$873M
$6M 0.06%
2,174,262
+1,827,459
+527% +$4.73M
CNTA
434
DELISTED
Centessa Pharmaceuticals
CNTA
$6M 0.06%
+247,387
New +$4.4M
CASS icon
435
Cass Information Systems
CASS
$712M
$5.96M 0.06%
151,528
-16,552
-10% -$706K
INDV icon
436
Indivior Pharmaceuticals
INDV
$4.75B
$5.94M 0.06%
+246,524
New +$5.16M
VLGEA icon
437
Village Super Market
VLGEA
$651M
$5.94M 0.06%
159,011
+17,338
+12% +$637K
NOG icon
438
Northern Oil and Gas
NOG
$2.27B
$5.93M 0.06%
239,191
-13,700
-5% -$363K
CDNA icon
439
CareDx
CDNA
$1.97B
$5.88M 0.06%
404,394
-374,210
-48% -$5.33M
ODC icon
440
Oil-Dri
ODC
$1.42B
$5.84M 0.06%
95,700
-243,300
-72% -$14.8M
BRK.B icon
441
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.78M 0.06%
11,500
+500
+5% +$242K
OSW icon
442
OneSpaWorld
OSW
$2.64B
$5.71M 0.06%
270,059
+50,003
+23% +$1.09M
SEM
443
DELISTED
Select Medical
SEM
$5.64M 0.06%
439,505
+39,300
+10% +$524K
MBC icon
444
MasterBrand
MBC
$1.04B
$5.64M 0.06%
428,454
-247,316
-37% -$3.06M
CIVB icon
445
Civista Bancshares
CIVB
$601M
$5.58M 0.06%
+274,958
New +$5.78M
LTH icon
446
Life Time Group Holdings
LTH
$9.84B
$5.56M 0.06%
201,544
+39,004
+24% +$1.11M
LFMD icon
447
LifeMD
LFMD
$176M
$5.53M 0.06%
814,451
+44,000
+6% +$363K
MCFT icon
448
MasterCraft Boat Holdings
MCFT
$597M
$5.51M 0.05%
256,702
+26,186
+11% +$547K
CYTK icon
449
Cytokinetics
CYTK
$10.9B
$5.5M 0.05%
+100,083
New +$4.12M
BOKF icon
450
BOK Financial
BOKF
$8.57B
$5.47M 0.05%
49,104
-7,060
-13% -$755K

Similar funds

Royce & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Royce & Associates held 840 positions worth $10B, up 2.9% from $9.74B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Royce & Associates withdrew a net $560M in Q3 2025, closing 78 positions and reducing 332 holdings. Its most notable exit was Sapiens International, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Aebi Schmidt Holding AG worth $16.6M.

  • Royce & Associates's largest Q3 2025 buy was Aebi Schmidt Holding AG: 1,331,821 shares worth $16.6M.
  • Royce & Associates added most to Bath & Body Works in Q3 2025, an estimated $26.8M increase.
  • Royce & Associates's biggest Q3 2025 reduction was Air Lease Corp, cutting an estimated $64.5M.
  • Royce & Associates fully exited Sapiens International in Q3 2025, selling an estimated $31.5M.
  • Royce & Associates's ten largest holdings make up 8.9% of its $10B portfolio in Q3 2025.
  • Royce & Associates opened 58 new positions and closed 78 in Q3 2025.
  • Royce & Associates's portfolio value rose 2.9% quarter-over-quarter to $10B.

Based on Royce & Associates's 13F filing for Q3 2025, filed 12 Nov 2025.